Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
387 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03368547 | 68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery | completed | N/A | 400 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT04777708 | BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer | terminated | Early Phase 1 | 1 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT02683200 | MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer | completed | Early Phase 1 | 21 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT03411070 | SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer | completed | Early Phase 1 | 27 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 17, 2023 | clinicaltrials |
| NCT04457245 | Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer(PSMA-dRT) | terminated | Phase 3 | 54 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 17, 2023 | clinicaltrials |
| NCT04928820 | 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy | terminated | Phase 2 | 22 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 21, 2022 | clinicaltrials |
| NCT02049593 | PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 44 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 26, 2022 | clinicaltrials |
| NCT03128619 | Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer | terminated | Phase 1 | 10 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 26, 2022 | clinicaltrials |
| NCT04279561 | Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer | terminated | Phase 1 | 9 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 21, 2022 | clinicaltrials |
| NCT02310594 | Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy | terminated | — | 139 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT02880020 | Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery | completed | Phase 2 | 36 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT02681601 | Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer | terminated | N/A | 2 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT03025139 | Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)(PTW) | unknown | N/A | 96 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 21, 2022 | clinicaltrials |
| NCT04460495 | Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRI | terminated | N/A | 8 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT03745690 | Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Mar 17, 2022 | clinicaltrials |
| NCT04069910 | Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases | withdrawn | N/A | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2022 | clinicaltrials |
| NCT00910650 | Study of Gene Modified Immune Cells in Patients With Advanced Melanoma(F5) | completed | Phase 2 | 14 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 6, 2021 | clinicaltrials |
| NCT03409419 | PET Imaging of the Immune System Using Analog Probes | completed | — | 4 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 12, 2021 | clinicaltrials |
| NCT04050215 | 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer | completed | Phase 2 | 937 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 30, 2021 | clinicaltrials |
| NCT01826877 | Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer | completed | Phase 1 | 12 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 4, 2021 | clinicaltrials |
| NCT02879994 | Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 11 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT02928510 | Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma | terminated | — | 1 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT02940262 | Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy | completed | Phase 3 | 1,138 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 2, 2021 | clinicaltrials |
| NCT04348682 | Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging | approved for marketing | — | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 24, 2021 | clinicaltrials |
| NCT01912820 | Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery | completed | Phase 1 | 32 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 23, 2021 | clinicaltrials |
| NCT04429204 | Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma | withdrawn | N/A | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 14, 2021 | clinicaltrials |
| NCT00060086 | Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer | completed | N/A | 47 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 4, 2021 | clinicaltrials |
| NCT04854044 | ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma | withdrawn | Phase 1 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT01410630 | FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma | completed | — | 66 | Jonsson Comprehensive Cancer CenterOTHER | 2 | May 11, 2021 | clinicaltrials |
| NCT03425461 | Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma | terminated | Phase 1 | 6 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Apr 2, 2021 | clinicaltrials |
| NCT00344799 | Cytogenetic Study of Ocular Melanoma | completed | — | 95 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Mar 29, 2021 | clinicaltrials |
| NCT00685516 | Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery | completed | N/A | 113 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 31, 2020 | clinicaltrials |
| NCT04282824 | Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer(MSG PSMA PET) | completed | Early Phase 1 | 14 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT01059513 | Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer | completed | — | 167 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 25, 2020 | clinicaltrials |
| NCT04399824 | Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer | withdrawn | N/A | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 6, 2020 | clinicaltrials |
| NCT01635283 | Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma | completed | Phase 2 | 5 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT00471887 | Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma | completed | Phase 2 | 32 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 26, 2020 | clinicaltrials |
| NCT03515577 | Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery(PSMA vs AXUMIN) | completed | Phase 2 | 50 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT00033514 | Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression | completed | Phase 1 / Phase 2 | 27 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT02866994 | Project Connect Online: An Internet-based Intervention for Women With Breast Cancer(PCO) | completed | N/A | 33 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 1, 2020 | clinicaltrials |
| NCT01532362 | Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer | terminated | N/A | 1 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 22, 2020 | clinicaltrials |
| NCT01013285 | Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma | completed | Phase 2 | 70 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 21, 2020 | clinicaltrials |
| NCT02015559 | Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus | completed | Phase 2 | 61 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 21, 2020 | clinicaltrials |
| NCT02357121 | Focal Laser Ablation of Prostate Tissue(FLA) | completed | Early Phase 1 | 11 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 21, 2020 | clinicaltrials |
| NCT00068341 | Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer | completed | Phase 2 | 74 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT01784640 | Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer | completed | Phase 1 | 13 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 3, 2020 | clinicaltrials |
| NCT00049257 | Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 58 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 1, 2020 | clinicaltrials |
| NCT00049322 | Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery | completed | Phase 2 | 30 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 1, 2020 | clinicaltrials |
| NCT00276614 | Bortezomib in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | 4 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 1, 2020 | clinicaltrials |
| NCT00998010 | Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma | completed | Phase 2 | 24 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 28, 2020 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials